Health-Related Quality of Life and Sleep Quality after 12 Months of Treatment in Nonsevere Obstructive Sleep Apnea: A Randomized Clinical Trial with Continuous Positive Airway Pressure and Mandibular Advancement Splints

Table 4

Number of patients with improved SF36 scores according to RCI (>1.96) and PSQI global score according to RCI (<−1.96), based on intention-to-treat analysis.

	Significantly improved HRQoL or sleep quality
	CPAP (n = 55)	MAS (n = 49)
Physical functioning	16.4% (9/55)	12.2% (6/49)	0.55
Role-physical	12.7% (7/55)	12.2% (6/49)	0.94
Bodily pain	7.3% (4/55)	10.2% (5/49)	0.73^F
General health	21.8% (12/55)	28.6% (14/49)	0.43
Vitality	36.4% (20/55)	44.9% (22/49)	0.38
Social functioning	12.7% (7/55)	18.4% (9/49)	0.43
Role-emotional	9.1% (5/55)	12.2% (6/49)	0.60
Mental health	14.5% (8/55)	22.4% (11/49)	0.30
Physical component	10.9% (6/55)	8.2% (4/49)	0.75^F
Mental component	18.2% (10/55)	20.4% (10/49)	0.77
PSQI global score	18.2% (10/55)	32.7% (16/49)	0.09

HRQoL: health-related quality of life; RCI: reliable change index; PSQI: Pittsburgh Sleep Quality Index (global score); SF36: Short Form 36 (8 domains + 2 aggregated scales); CPAP: continuous positive airway pressure; MAS: mandibular advancement splint; P: Pearson chi-square test; F: Fisher’s exact test. Significant correlation to PSQI global score.